跳至主要内容
临床试验/NCT05910242
NCT05910242已完成不适用

Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension

Yi Yang1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2023年6月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
102
试验地点
1
主要终点
Mean systolic blood pressure

研究概览

简要总结

The purpose of this study is to determine the efficacy and safety of remote ischemic conditioning in the treatment of essential hypertension.

详细描述

Current studies have shown that remote ischemic conditioning can improve vascular endothelial function, inhibit sympathetic nervous system activity and regulate immune and inflammatory reactions. Thus it may exert anti-hypertensive effects through multiple mechanisms. The purpose of this study is to investigate the efficacy and safety of remote ischemic conditioning on blood pressure patients with essential hypertension.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age≥18 years, regardless of sex;
  • Patients with systolic blood pressure ≥140mmHg with or without taking oral antihypertensive drugs
  • Signed and dated informed consent is obtained

排除标准

  • Secondary hypertension;
  • Clinical blood pressure ≥ 180/110 mmHg or 24-hour mean arterial pressure ≥ 170/100 mmHg;
  • Severe organ dysfunction or failure;
  • Severe hematologic disorders or significant coagulation abnormalities;
  • History of atrial fibrillation or myocardial infarction within 6 months;
  • Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;
  • Individuals who will or have received anticoagulant therapy with drugs such as dabigatran, rivaroxaban, warfarin, etc; ;
  • Pregnant or lactating women;
  • Those who are participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to enrollment;
  • Other conditions that the researchers think are not suitable for the project.

研究组 & 干预措施

RIC group

Active Comparator

Patients are treated with remote ischemic conditioning (RIC).

干预措施: Remote ischemic conditioning (Procedure)

Sham RIC group

Sham Comparator

Patients are treated with sham remote ischemic conditioning (sham-RIC).

干预措施: Sham remote ischemic conditioning (Procedure)

结局指标

主要结局

Mean systolic blood pressure

时间窗: 1-7 days

Difference in mean systolic blood pressure during RIC/sham-RIC between two groups.

次要结局

  • Mean diastolic blood pressure(1-7 days)

研究者

发起方
Yi Yang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yi Yang

Associated Dean of The First Hospital of Jilin University

The First Hospital of Jilin University

研究点 (1)

Loading locations...

相似试验

Efficacy and Safety of Remote Ischemic Conditioning... | 临床试验